During the development of obesity, dysbiosis in gut microbiota increased the production of LPS mainly in the HFS group, which could activate TLR4 and promote the induction of NF-κB, provoking the expression of inflammatory cytokines and ROS production. The gene discussed is TLR4; the disease is obesity disorder.